SKSuchitra Kamle

Suchitra Kamle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suchitra Kamle has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Abhishek Ojha

    Structural and Computational Biology Lab, International Centre for Genetic Engineering and Biotechnology

    2 shared publications
  • Arvind Kumar

    Banaras Hindu University

    2 shared publications
  • Dawei Li

    School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China; Engineering Research Center of Cell and Therapeutic Antibody of Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Guangwei Gao

    School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Hema Negi

    School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Zheqi Li

    School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease

    by Songhua Zhang, Aryanna Sousa, Mengqui Lin, Ayako Iwano, Rishubh Jain, Bing Ma, Chang Min Lee, Jin Wook Park, Suchitra Kamle, Rolf Carlson, et al.

    A recently discovered human glycoprotein, chitinase 3-like 1 (Chi3L1), may play a role in inflammation, tissue remodeling, and visceral fat accumulation. We hypothesize that Chi3L1 gene expression is important in the development of hepatic insulin resistance characterized by the generation of pAKT, pGSK, and pERK in wild type and Chi3L1 knockout (KO) murine liver following insulin stimulation. The Chi3L1 gene and protein expression was evaluated by Real Time PCR and ELISA; lipid accumulation in hepatocytes was also assessed. To alter Chi3L1 function, three different anti-Chi3L1 monoclonal antibodies (mAbs) were administered in vivo and effects on the insulin signaling cascade and hepatic lipid deposition were determined. Transmission of the hepatic insulin signal was substantially improved following KO of the CHi3L1 gene and there was reduced lipid deposition produced by a HFD. The HFD-fed mice exhibited increased Chi3L1 expression in the liver and there was impaired insulin signal transduction. All three anti-Chi3L1 mAbs partially restored hepatic insulin sensitivity which was associated with reduced lipid accumulation in hepatocytes as well. A KO of the Chi3L1 gene reduced lipid accumulation and improved insulin signaling. Therefore, Chi3L1 gene upregulation may be an important factor in the generation of NAFLD/NASH phenotype.


  • Open Access

    Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration

    by Zheqi Li, Zhenghua Wu, Hao Chen, Qi Zhu, Guangwei Gao, Lingyun Hu, Hema Negi, Suchitra Kamle, Dawei Li

    Anterior gradient 2 (AGR2) is a promising anti-tumor target associated with estrogen receptor expression and metastatic progression of breast cancer. Insulin-like growth factor-1 (IGF-1) is another potent factor that stimulates breast cancer progression and mediates anti-estrogen drug resistance. However, the precise mechanism and connections between these two factors in breast cancer drug resistance have not been fully elucidated. Here, for the first time, we decipher that IGF-1 remarkably induces AGR2 in the MCF7 cell line, through an estrogen response element (ERE) between −802 and −808 bp and a leucine zipper transcription factor-binding site located between −972 and −982 bp on the AGR2 promoter. We also found that the ERK1/2 and AKT pathways mediate estrogen receptor-α at the upstream of ERE and that the JNK pathway activates the leucine zipper site through the c-Jun/c-Fos complex. Additionally, our data suggest that knockdown of AGR2 reduces IGF-1-induced cell proliferation, migration and cell cycle progression. Therefore, we report that AGR2 is a key modulator involved in IGF-1-induced breast cancer development. We propose that the identification of the mechanism linking the IGF-1/insulin signal and AGR2 promoter activation is important, because it provides insights into the development of anti-breast cancer drugs.


  • Open Access

    Sal‐like protein 2 upregulates p16 expression through a proximal promoter element

    by Zhenghua Wu, Kebin Cheng, Lidan Shi, Zheqi Li, Hema Negi, Guangwei Gao, Suchitra Kamle, Dawei Li

    Sal‐like protein 2 (Sall2), a homeotic transcription factor, is a putative tumor suppressor. We have previously shown that Sall2 activates the transcription of tumor suppressor gene p21 and suppresses tumorigenesis through cell cycle inhibition and induction of apoptosis. To investigate additional Sall2‐regulated downstream genes, we analyzed the differences in mRNA expression profiles with and without exogenously expressed Sall2. We identified 1616 Sall2‐responsive genes through gene expression arrays. Promoter‐reporter assays of p16INK4A and several other tumor‐related genes indicated that the Sall2 regulation of these promoters was not significantly different between the two major forms of Sall2 with alternative exon 1 or exon 1A. Additional analysis showed that Sall2‐induced p16 promoter activation was Sall2 dose‐dependent. Deletion and site‐directed mutagenesis of the p16 promoter identified a consensus Sall2 binding site (GGGTGGG) proximal to the p16 transcription start site and was critical for p16 promoter activation. Finally, to confirm the significance of Sall2‐activated p16 expression in cell cycle regulation, we co‐transfected the SKOV3 cells with a Sall2 expression construct and a p16 minigene and also co‐transfected the ES‐2 cells with a Sall2 expression construct and the siRNA against p16 for flow cytometry analysis. Our results showed that Sall2 enhanced the p16 minigene blocking of cell cycle progression and p16 knockdown with siRNA abolished most of the Sall2 inhibition of cell cycle progression. These findings indicate that Sall2 targets multiple cell cycle regulators, including p16, through their promoters, adding knowledge to the understanding of Sall2 and p16 gene regulation, and how Sall2 deregulation may promote cancer formation.


  • Development of Enzyme-Linked Immunosorbent Assay for the Detection of Bt Protein in Transgenic Cotton

    by Suchitra Kamle, Abhishek Ojha, Arvind Kumar

    Enzyme-linked immunosorbent assays (ELISA) are being used extensively for the identification of Bt-protein in Bt transgenic crops. A sandwich ELISA test is the most preferable immunoassay for the quantification of Bt-protein in transgenic cotton plants. Here, we describe development of sandwich ELISA, employing polyclonal rabbit antibody as a capture antibody and HRP-labeled mouse anti-Bt protein-antibody as a detector antibody.


  • Development of an enzyme linked immunosorbant assay for the detection of Cry2Ab Protein in transgenic plants

    by Suchitra Kamle, Abhishek Ojha, Arvind Kumar

    Immunoassays' a sensitive technique has a wide application for detection of antigen, especially for the detection of growing genetically modified crops, which are underwent field trial. Here, we have developed for the quantitative detection of Cry2Ab protein expressed in GM crops. A Cry2Ab-rabbit-IgG act as capture antibody and Cry2Ab mouse monoclonal antibody behave as a detecting antibody, which is employed in sandwich ELISA. A 2% polyvinylpyrrollidone and 1% dithiothritol was utilized in protein extraction from cotton seed to avert interfering agents. The developed assay was validated with GM cotton samples, limit of detection was found 1 pg/ml and range to a limit of quantification 16 pg/ml. The developed immunoassay does not show any cross reactivity with other non target GM proteins like Cry1Ab, Cry1Ac, EPSPS, Vip.


  • Development of multiplex and construct specific PCR assay for detection of cry2Ab transgene in genetically modified crops and product

    by Suchitra Kamle, Arvind Kumar, Raj K. Bhatnagar

    An efficient detection system for trait validation and screening of GMOs is a much sought after procedure, which could also help in regulatory compliance. Currently, in India, a number of cry2Ab transgene carrying GM crops are undergoing field trial i.e., MON15985 cotton, Bt rice, Bt okra, Bt corn, Bt brinjal, Bt potato and Bt tomato. In this study, we report a qualitative assay for detection for cry2Ab (326 bp). Further, the amplification compatibility with promoter, p35S (195 bp), terminator, t-nos (180 bp) and marker gene, npt II (215 bp) was also confirmed using Bt cotton event MON15985 as reference material. The detection sensitivity was 0.1% that is far below the requirement of the stringent European Union (EU) regulations of 0.9%. The target DNA when spiked with either MECH-12 (cry1Ac), RR-soya (epsps) or MON-810 (cry1Ab) showed no inhibitory effect on cry2Ab detection. Moreover, the cry2Ab specific transgene construct (1.9 kb) was amplified and its identity confirmed by a nested PCR. Hence, a comprehensive multiplex PCR method for detection of cry2Ab gene in a GM crop/products was established. This is possibly a first report showing concurrent amplification of cry2Ab transgene, promoter, terminator and marker gene.